Latuda: An Evaluation of Its Usefulness

With nine other atypical antipsychotics already on the market (some of which are available as generics), did we really need another one? Given the pesky side effects of antipsychotics, maybe we did. Let’s take a look at what we know so far about Latuda (lurasidone) in an effort to figure out how to incorporate it into our clinical toolbox. Latuda was first approved by the US Food and Drug Administration (FDA) for use in schizophrenia in late 2010.

Expert QA

Side Effects of Antipsychotics in Children

Aat a certain point [in my research career], with all the children and adolescents who were being prescribed psychiatric medications, I thought that the adverse effects of antipsychotics in this young patient population were worth examining.